Overview
Portfolio
More
Bigpi
Athens, Greece
We partner with teams developing exceptional technologies or ingenious business models, investing where we see opportunities to change people’s lives for the better or transform whole industries, providing capital and ad...
Portfolio
27+
Employees
15+
Founded
2018
AUM
≈ $275.0M
Investment focus
Stages
No stages listed
Industries
No industries listedFund details
Funds
Big Pi II
Vintage 2023
Big Pi I
Big Pi Growth I
Vintage 2025 • $220.0M
Sources
Bigpi
We partner with teams developing exceptional technologies or ingenious business models, investing where we see opportunities to change people’s lives for the better or transform whole industries, providing capital and advice drawn from our experience.
Portfolio
27+
Employees
15+
Founded
2018
AUM
≈ $275.0M
Funds
Big Pi II · Vintage 2023
Big Pi I
Big Pi Growth I · Vintage 2025 • $220.0M
Showing 18 of 18 matched portfolio companies
Acumino provides an AI‑driven analytics platform that automatically ingests, processes, and visualizes structured and unstructured data from multiple sources in real time. Using NLP and machine‑learning models, it categorizes, summarizes, and highlights key trends, delivering interactive dashboards and alerting tools that can be embedded into existing workflows via APIs and webhooks.
Funding: $4.0M
Rough estimate of the amount of funding raised
Funding: $4.0M
Rough estimate of the amount of funding raised
AliciaBots provides autonomous, multi-disciplinary robot teams for on-demand workforce augmentation. These agents perform real-time hull cleaning and condition monitoring for maritime vessels without interrupting voyages. The service delivers proactive decision-making, optimized fuel efficiency, and reduced operational risk for ship owners.
Altered provides a dual‑platform voice AI suite: Altered Studio for high‑quality speech‑to‑speech voice morphing and custom voice cloning used in media production, and RealTime Pro for low‑latency voice transformation during live calls, gaming, or streaming. Both tools run on standard CPUs, keep audio processing local for privacy, and let users change identity, accent, age, gender, or restore impaired speech while preserving natural tempo and inflection.
Anodyne develops the HeroPatch, a transdermal delivery system that administers multi-milligram doses of large molecules, enabling tunable pharmacokinetic profiles and room temperature stability. The company focuses on chronic diseases, starting with obesity, by providing easier access to complex formulations and combination therapies.
Bryq offers a talent assessment platform that utilizes objective data to evaluate both hard and soft skills, ensuring candidates align with job requirements and company culture. This approach reduces employee churn and time-to-hire while enhancing the quality of hires, enabling organizations to make informed, data-driven recruitment decisions.
Funding: $4.0M
Rough estimate of the amount of funding raised
Funding: $4.0M
Rough estimate of the amount of funding raised
Corsmed offers an MRI simulator that enables users to conduct hands-on training by configuring hardware, setting up patients, and adjusting imaging parameters on their laptops. This platform provides unlimited access to realistic MRI training, enhancing skill development and onboarding for individuals and organizations at a fraction of the cost of traditional training methods.
Funding: $6.7M
Rough estimate of the amount of funding raised
Funding: $6.7M
Rough estimate of the amount of funding raised
Cylinder is a digital health platform that provides individualized, clinician-backed care plans for digestive health, utilizing virtual access to a team of doctors, dietitians, and health coaches. The platform addresses gastrointestinal issues affecting 40% of the population daily, delivering measurable outcomes such as a 5:1 return on investment and significant reductions in emergency room costs.
Funding: $47.0M
Rough estimate of the amount of funding raised
Funding: $47.0M
Rough estimate of the amount of funding raised
Dataviva offers a low-code, real-time planning platform that integrates AI and decision algorithms with human expertise to enhance retail supply chain management. This technology enables retailers to automate demand forecasting, optimize inventory, and reduce decision-making time, resulting in improved sales and reduced overstock.
Intelligencia utilizes machine learning algorithms to provide accurate probability of success assessments for drug development, enabling pharmaceutical companies to identify and quantify risks across various therapeutic areas. By offering transparent AI-driven insights, the platform enhances decision-making and optimizes clinical trial design, ultimately increasing the likelihood of successful drug approvals.
Funding: $26.4M
Rough estimate of the amount of funding raised
Funding: $26.4M
Rough estimate of the amount of funding raised
The startup offers an AI-powered mobile application that curates and summarizes scientific publications, clinical studies, and medical guidelines for healthcare professionals. By providing personalized medical journal databases, the platform enables users to efficiently access trustworthy information and stay current with the latest clinical research.
Navenio provides indoor location positioning services through a mobile app that employs sensor fusion techniques and algorithms to accurately determine user locations in environments where GPS is ineffective. This technology enables hospital care teams to efficiently navigate and coordinate care in complex indoor settings.
Funding: $53.0M
Rough estimate of the amount of funding raised
Funding: $53.0M
Rough estimate of the amount of funding raised
Provides personalized telehealth services offering clinically-proven treatments for conditions like erectile dysfunction, low testosterone, weight loss, and hair loss. Utilizes online consultations, tailored medication plans, and regular blood tests to diagnose, monitor, and optimize patient health, ensuring discreet delivery and ongoing clinical support from UK-licensed professionals.
Nutropy utilizes precision fermentation to produce bioidentical milk ingredients from programmed yeast, enabling the creation of animal-free cheese alternatives. This approach significantly reduces resource consumption, greenhouse gas emissions, and eliminates lactose and cholesterol, addressing the environmental and health impacts of traditional dairy farming.
Funding: $5.4M
Rough estimate of the amount of funding raised
Funding: $5.4M
Rough estimate of the amount of funding raised
Orfium provides a software platform that automates music rights management, enabling music publishers, record labels, and broadcasters to efficiently track, license, and monetize their content across digital channels. By streamlining cue sheet management and license processing, Orfium enhances revenue generation and operational efficiency for its clients in the entertainment industry.
The startup develops injectable bio-structural gel implants that are administered into the nucleus of intervertebral discs to restore mechanical function and alleviate back pain. This micro-invasive procedure, completed in under 30 minutes, creates a supportive scaffold that suppresses degenerative processes in spinal discs.
Funding: $15.4M
Rough estimate of the amount of funding raised
Funding: $15.4M
Rough estimate of the amount of funding raised
The startup develops a wearable, non-invasive medical device and a mobile application that continuously monitor and record symptoms of Parkinson's disease. This system enhances patient-physician communication and supports clinical decision-making by providing real-time, objective data on symptom progression.
The startup develops a surface modeling tool that utilizes proprietary algorithms to create natural free-form curves and generate watertight, smooth surfaces. This technology enables users to efficiently design and manipulate complex three-dimensional shapes, significantly reducing the time required for surface design and editing.
Saphetor provides the VarSome Suite, a set of bioinformatics solutions that processes Next Generation Sequencing (NGS) data to generate clinically relevant genetic variation information. This technology enables healthcare professionals and researchers to access a comprehensive knowledge base and automated classification tools, enhancing the accuracy and efficiency of genomic analysis.
Funding: $4.2M
Rough estimate of the amount of funding raised
Funding: $4.2M
Rough estimate of the amount of funding raised
Showing 9 of 9 unmatched portfolio companies